Factor | RH | 95% CI | p-value |
---|---|---|---|
1 month after HSCT | |||
Sibling donor | 1.23 | 0.95–1.61 | 0.13 |
aGVHD | 0.76 | 0.58–0.99 | < 0.05 |
2 months after HSCT | |||
Sibling donor | 1.31 | 1.01–1.70 | < 0.05 |
CMV infection | 0.83 | 0.64–1.08 | 0.17 |
aGVHD | 0.70 | 0.55–0.90 | < 0.01 |
3 months after HSCT | |||
Sibling donor | 2.23 | 1.34–3.71 | 0.004 |
aGVHD | 0.91 | 0.70–1.20 | 0.50 |
ATG | 1.66 | 0.99–2.78 | 0.06 |
6 months after HSCT | |||
Sibling donor | 1.86 | 1.21–2.86 | < 0.01 |
aGVHD | 0.77 | 0.58–1.04 | 0.09 |
ATG | 1.30 | 0.83–2.04 | 0.26 |
12 months after HSCT | |||
Sibling donor | 1.30 | 0.97–1.74 | 0.09 |
HLA-Mismatch | 2.12 | 1.59–2.82 | < 0.001 |